Efficacy and safety of two artificial saliva-based polymers containing 0.1% pilocarpine for treatment of xerostomia: A randomized clinical pilot trial

BACKGROUND: Topical agents are the mainstay in the treatment of xerostomia, a common complaint most frequently associated with salivary dysfunction. This study aimed to compared the efficacy and safety for xerostomia treatment of 2 artificial saliva preparations containing 0.1% pilocarpine, and, eit...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarideechaigul, Wilairat, Priprem, Aroonsri, Limsitthichaikoon, Sucharat, Phothipakdee, Pensri, Chaijit, Rajda, Jorns, Teekayu P., Lungruammit, Nopphakhun, Chaiya, Krittiporn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501859/
https://www.ncbi.nlm.nih.gov/pubmed/34667494
http://dx.doi.org/10.4317/jced.58415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8501859/
https://www.ncbi.nlm.nih.gov/pubmed/34667494
http://dx.doi.org/10.4317/jced.58415

Ejemplares similares